About AETHLON MEDICAL INC
Aethlon Medical, Inc. (AEMD) is a company developing the Hemopurifier®, a clinical-stage therapeutic device designed to selectively remove circulating pathogenic targets from biologic fluids, with FDA Breakthrough Device designations in oncology and infectious disease.
Development of immunotherapeutic technologies to combat cancer and infectious diseasesDesign and clinical development of the Hemopurifier® for the rapid depletion of cancer-promoting exosomes and circulating virusesConducting safety, feasibility, and dose-finding clinical trials in cancer patients with solid tumors
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| TOPIC 359: A DEVICE PROTOTYPE FOR ISOLATION OF MELANOMA EXOSOMES FOR DIAGNOSTICS AND TREATMENT MONITORING | Department of Health and Human Services | $1.9M |
Is this your company?
Claim AETHLON MEDICAL INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim AETHLON MEDICAL INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.